Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

16. October 2018

Epigenomics AG sets subscription price at EUR 1.86 per new share

Read more

03. October 2018

Epigenomics AG plans to increase share capital with subscription rights for existing shareholders / Commitment of major shareholder to participate in planned capital increase

Read more

09. June 2018

Centers for Medicare & Medicaid Services publish preliminary rate of $192 for Epigenomics’ colorectal cancer screening test Epi proColon®

Read more

Press releases

03. May 2019

CMS accepts Epigenomics’ application for NCD review

Read more

27. March 2019

Epigenomics AG Reports Results for Financial Year 2018

Read more

15. March 2019

U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill

Read more